Neoadjuvant Chemotherapy in Combination With Toripalimab for HR+/HER2- Breast Cancer : a Randomized, Open-label, Parallel-controlled, Multi-center Phase III Study (NEOTORCH-BREAST04)
Clinical trial NCT06977893 · RECRUITING
Trial details
- NCT number
- NCT06977893
- Sponsor
- First Affiliated Hospital of Zhejiang University
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-24
- Primary completion
- 2027-03-23
- Enrollment
- 194
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.